Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 5
2019 4
2020 9
2021 9
2022 6
2023 6
2024 8
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics and Pharmacodynamics of Posaconazole.
Chen L, Krekels EHJ, Verweij PE, Buil JB, Knibbe CAJ, Brüggemann RJM. Chen L, et al. Among authors: buil jb. Drugs. 2020 May;80(7):671-695. doi: 10.1007/s40265-020-01306-y. Drugs. 2020. PMID: 32323222 Free PMC article. Review.
A mould infection in disguise.
Buil JB, Pickkers P, van der Lee HAL, Verweij PE. Buil JB, et al. Clin Microbiol Infect. 2021 Jun;27(6):854-855. doi: 10.1016/j.cmi.2020.11.020. Epub 2020 Nov 27. Clin Microbiol Infect. 2021. PMID: 33253945 Free article. No abstract available.
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.
Vanderbeke L, Janssen NAF, Bergmans DCJJ, Bourgeois M, Buil JB, Debaveye Y, Depuydt P, Feys S, Hermans G, Hoiting O, van der Hoven B, Jacobs C, Lagrou K, Lemiale V, Lormans P, Maertens J, Meersseman P, Mégarbane B, Nseir S, van Oers JAH, Reynders M, Rijnders BJA, Schouten JA, Spriet I, Thevissen K, Thille AW, Van Daele R, van de Veerdonk FL, Verweij PE, Wilmer A, Brüggemann RJM, Wauters J; Dutch-Belgian Mycosis Study Group. Vanderbeke L, et al. Among authors: buil jb. Intensive Care Med. 2021 Jun;47(6):674-686. doi: 10.1007/s00134-021-06431-0. Epub 2021 May 29. Intensive Care Med. 2021. PMID: 34050768 Free PMC article. Clinical Trial.
Antifungal Resistance in Pulmonary Aspergillosis.
Verweij PE, Song Y, Buil JB, Zhang J, Melchers WJG. Verweij PE, et al. Among authors: buil jb. Semin Respir Crit Care Med. 2024 Feb;45(1):32-40. doi: 10.1055/s-0043-1776997. Epub 2024 Jan 9. Semin Respir Crit Care Med. 2024. PMID: 38196063
Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis1.
Janssen NAF, Nyga R, Vanderbeke L, Jacobs C, Ergün M, Buil JB, van Dijk K, Altenburg J, Bouman CSC, van der Spoel HI, Rijnders BJA, Dunbar A, Schouten JA, Lagrou K, Bourgeois M, Reynders M, van Regenmortel N, Rutsaert L, Lormans P, Feys S, Debavaye Y, Tamion F, Costa D, Maizel J, Dupont H, Chouaki T, Nseir S, Sendid B, Brüggemann RJM, van de Veerdonk FL, Wauters J, Verweij PE. Janssen NAF, et al. Among authors: buil jb. Emerg Infect Dis. 2021 Nov;27(11):2892-2898. doi: 10.3201/eid2711.211174. Epub 2021 Sep 14. Emerg Infect Dis. 2021. PMID: 34519638 Free PMC article.
51 results